Literature DB >> 17654664

Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.

Jason D Wright1, Perry W Grigsby, Rebecca Brooks, Matthew A Powell, Randall K Gibb, Feng Gao, Janet S Rader, David G Mutch.   

Abstract

BACKGROUND: Removal of the parametrial soft tissue is recommended for patients with cervical cancer undergoing radical hysterectomy. Parametrectomy results in significant morbidity. The objective of the study was to determine factors predictive of parametrial tumor spread and to define a subset of patients at low risk for parametrial disease.
METHODS: Patients with invasive cervical cancer who underwent radical hysterectomy from 1989-2005 were examined. Analysis was performed to determine factors associated with parametrial tumor spread. Survival estimates were determined using the Kaplan-Meier method.
RESULTS: A total of 594 patients were identified. Parametrial metastases were documented in 64 (10.8%). Factors associated with parametrial disease were: histology, advanced grade, deep cervical invasion, lymphovascular space invasion (LVSI), large tumor size, advanced stage, uterine or vaginal involvement, and pelvic or para-aortic lymph node metastases (P < .0001 for each). Parametrial metastases were associated with increased risk of recurrence and decreased disease-free and overall survivals (P < .0001). A subgroup analysis was performed to identify patients at low risk for parametrial spread. In pelvic node-negative women parametrial disease was noted in 6.0% (30/498) compared with 47.9% (34 of 71) of those with positive pelvic nodes (P < .0001). If further stratified to women with negative nodes, no LVSI, and tumors < 2 cm, the incidence of parametrial disease was only 0.4%.
CONCLUSIONS: Parametrial spread is a strong predictor of recurrence and decreased survival. Parametrial invasion is rare in patients with small tumors, no LVSI, and negative pelvic nodes (no poor prognostic factors). Further study is warranted to determine the feasibility of omitting parametrectomy in these low-risk patients. (c) 2007 American Cancer Society.

Entities:  

Mesh:

Year:  2007        PMID: 17654664     DOI: 10.1002/cncr.22899

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  42 in total

1.  Safety and tolerance of radical hysterectomy for cervical cancer in the elderly.

Authors:  Erin M George; Ana I Tergas; Cande V Ananth; William M Burke; Sharyn N Lewin; Eri Prendergast; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2014-04-24       Impact factor: 5.482

2.  Surgical management of early cervical cancer: the shape of future studies.

Authors:  Stefano Greggi; Cono Scaffa
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

Review 3.  Early Cervical Cancer: Current Dilemmas of Staging and Surgery.

Authors:  Tiffany Zigras; Genevieve Lennox; Karla Willows; Allan Covens
Journal:  Curr Oncol Rep       Date:  2017-08       Impact factor: 5.075

4.  New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.

Authors:  Andres A Roma; Toni-Ann Mistretta; Andrea Diaz De Vivar; Kay J Park; Isabel Alvarado-Cabrero; Golnar Rasty; Jose G Chanona-Vilchis; Yoshiki Mikami; Sung R Hong; Norihiro Teramoto; Rouba Ali-Fehmi; Denise Barbuto; Joanne K L Rutgers; Elvio G Silva
Journal:  Gynecol Oncol       Date:  2016-04       Impact factor: 5.482

5.  Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies.

Authors:  Sileny N Han; Mina Mhallem Gziri; Kristel Van Calsteren; Frédéric Amant
Journal:  Ther Adv Med Oncol       Date:  2013-07       Impact factor: 8.168

Review 6.  Cervical cancer.

Authors:  Pierre Leonard Martin-Hirsch; Nicholas James Wood
Journal:  BMJ Clin Evid       Date:  2011-07-27

7.  Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy?

Authors:  Ashlee L Smith; Michael Frumovitz; Kathleen M Schmeler; Ricardo dos Reis; Alpa M Nick; Robert L Coleman; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2010-08-12       Impact factor: 5.482

Review 8.  Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care?

Authors:  Pedro T Ramirez; Rene Pareja; Gabriel J Rendón; Carlos Millan; Michael Frumovitz; Kathleen M Schmeler
Journal:  Gynecol Oncol       Date:  2013-09-14       Impact factor: 5.482

9.  Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.

Authors:  Anuj Suri; Michael Frumovitz; Michael R Milam; Ricardo dos Reis; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2008-10-25       Impact factor: 5.482

10.  "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer.

Authors:  Michael Frumovitz; Elizabeth D Euscher; Michael T Deavers; Pamela T Soliman; Kathleen M Schmeler; Pedro T Ramirez; Charles F Levenback
Journal:  Gynecol Oncol       Date:  2012-08-19       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.